WISE Indiana
Expert Directory Form

Regenstrief Institute COVID-19 Dashboard

Serious Illness Care Program COVID-19
Response Toolkit: Ariadne Labs

IUSM Library COVID-19
Research Guide

IUPUI COVID-19
ECHO Registration

Johns Hopkins COVID-19
POC Guide

NCBI LitCovid
Literature Hub

wisein@iu.edu | 317-274-7155

Toolkit for Healthcare Providers (IDOH)
This page contains guidance and tools to help clinicians make decisions, protect patients and employees, and communicate with their communities.

IDOH COVID-19 Page
Indiana FSSA COVID-19 Page

World Health Organization Weekly Epidemiological Update (WHO)
Over 2.6 million new cases were reported last week, a 7% increase compared to the previous week, following six consecutive weeks of declining numbers. The global case increase was driven by increases in the Eastern Mediterranean (14%), South-East Asia (9%), Europe (9%) and the Americas (6%). Possible reasons for this increase include the continued spread of more transmissible variants of concern (VOCs), relaxation of public health and social measures (PHSM) and fatigue around adhering to PSHM measures.

Emergency Use Authorization for Janssen COVID-19 Vaccine (FDA)
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of COVID-19 on February 27, 2021. The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

COVID-19 Forecasts: Hospitalizations (CDC)
This week’s national ensemble predicts that the number of new daily confirmed COVID-19 hospital admissions will likely decrease over the next 4 weeks, with 1,900 to 10,000 new confirmed COVID-19 hospital admissions likely reported on March 29, 2021.

COVID-19 Forecasts: Deaths (CDC)
This week’s national ensemble predicts that the number of newly reported COVID-19 deaths will likely decrease over the next 4 weeks, with 4,400 to 12,900 new deaths likely reported in the week ending March 27, 2021. The national ensemble predicts that a total of 540,000 to 564,000 COVID-19 deaths will be reported by this date.

WHO COVID-19 Page
CDC COVID-19 Page

These documents were prepared by teams of research librarians and faculty experts in response to specific questions posed by individuals involved in Indiana’s frontline COVID-19 response. They summarize information that frontline responders may find useful. Please note that information is current for the dates specified. New studies, priorities and literature are being published daily, and best practices are rapidly evolving. These documents do not represent clinical guidelines, standard operating procedures, or the opinions or positions of FSSA.

Recently Updated Questions

• Which SARS-CoV-2 vaccines have been approved for use in the US or are likely to be approved for use within the next three months, and what are their defining characteristics?